title: Treatment of an HBs-Ag positive stem cell donor with lamivudine to prevent the development of hepatitis B in the recipient.
authors.forename: Piccioni
authors.initials: P
authors.lastname: Paola
authors.forename: Laurenti
authors.initials: L
authors.lastname: Luca
authors.forename: Tarnani
authors.initials: T
authors.lastname: Michela
authors.forename: Chiusolo
authors.initials: C
authors.lastname: Patrizia
authors.forename: Sorà
authors.initials: S
authors.lastname: Federica
authors.forename: Piccirillo
authors.initials: P
authors.lastname: Nicola
authors.forename: Leone
authors.initials: L
authors.lastname: Giuseppe
authors.forename: Sica
authors.initials: S
authors.lastname: Simona
authors.forename: Grieco
authors.initials: G
authors.lastname: Antonio
mesh_terms: D006509:Hepatitis B / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine